Abstract
Bidens pilosa L. (Asteraceae) is routinely used in African pharmacopoeia for the management of inflammations, diarrhoea and cardiovascular disorders including hypertension. The implication of β-adrenomimetic agonist substances in the hypotension and vasodilatation induced by a chromatographic active fraction F2 of the leaves aqueous extract (BpF2) were investigated. BpF2 induced a dose-dependent hypotension (1 mg/kg b.w.- 25 mg/kg b.w.) in the rabbit. It caused a concentration dependent (10-12 mg/ml- 10-1 mg/ml) decrease in the force of contraction of the isolated guinea-pig aorta. The hypotension and vasodilatation elicited by BpF2 were attenuated in the presence of propranolol (a β-adrenoceptor antagonist). The results suggest that BpF2 could contain β-adrenomimetic agonist substances that may be partly responsible for the hypotension and the vasodilatation. This would therefore justify the use of the plant to treat hypertension.
Keywords: β-adrenomimetic agonists, propranolol, hypotension, vasodilatation
Current Bioactive Compounds
Title: β-Adrenomimetic Actions in the Hypotension and Vasodilatation Induced by a Chromatographic Active Fraction from Bidens pilosa L. (Asteraceae) in Mammals
Volume: 4 Issue: 1
Author(s): Kouakou Kouakou Leandre, Abo Kouakou Jean Claude, Datte Yao Jacques, Traore Flavien and Ehile Ehouan Etienne
Affiliation:
Keywords: β-adrenomimetic agonists, propranolol, hypotension, vasodilatation
Abstract: Bidens pilosa L. (Asteraceae) is routinely used in African pharmacopoeia for the management of inflammations, diarrhoea and cardiovascular disorders including hypertension. The implication of β-adrenomimetic agonist substances in the hypotension and vasodilatation induced by a chromatographic active fraction F2 of the leaves aqueous extract (BpF2) were investigated. BpF2 induced a dose-dependent hypotension (1 mg/kg b.w.- 25 mg/kg b.w.) in the rabbit. It caused a concentration dependent (10-12 mg/ml- 10-1 mg/ml) decrease in the force of contraction of the isolated guinea-pig aorta. The hypotension and vasodilatation elicited by BpF2 were attenuated in the presence of propranolol (a β-adrenoceptor antagonist). The results suggest that BpF2 could contain β-adrenomimetic agonist substances that may be partly responsible for the hypotension and the vasodilatation. This would therefore justify the use of the plant to treat hypertension.
Export Options
About this article
Cite this article as:
Leandre Kouakou Kouakou, Jean Claude Kouakou Abo, Jacques Yao Datte, Flavien Traore and Etienne Ehouan Ehile, β-Adrenomimetic Actions in the Hypotension and Vasodilatation Induced by a Chromatographic Active Fraction from Bidens pilosa L. (Asteraceae) in Mammals, Current Bioactive Compounds 2008; 4 (1) . https://dx.doi.org/10.2174/157340708784533438
DOI https://dx.doi.org/10.2174/157340708784533438 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review
Current Neuropharmacology Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Current Pharmaceutical Design Phytotherapeutic and Natural Compound Applications for Age-Related, Inflammatory and Serious Eye Ailments
Current Molecular Pharmacology Postoperative Care of the Transplanted Patient
Current Cardiology Reviews Polypharmacy in Cardiovascular Medicine: Problems and Promises!
Cardiovascular & Hematological Agents in Medicinal Chemistry A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin
Current Pharmaceutical Design Potential Mechanisms of Failure in the Sudden Infant Death Syndrome
Current Pediatric Reviews Controlled Release Inhalable Polymeric Microspheres for Treatment of Pulmonary Arterial Hypertension
Current Pharmaceutical Design Ganoderma lucidum: A Potent Pharmacological Macrofungus
Current Pharmaceutical Biotechnology Renin Inhibition as a New Strategy to Combat Cardiovascular Disease
Current Hypertension Reviews A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems
Current Pharmaceutical Design Hypotensive Effect of Hydroalcoholic Ziziphus jujuba Extract on Normotensive Rats
Current Nutrition & Food Science On the Origin of Cortical Dopamine: Is it a Co-Transmitter in Noradrenergic Neurons?
Current Neuropharmacology Role of Adiponectin in Obesity, Hypertension, and Metabolic Syndrome
Current Hypertension Reviews The Intriguing Phospholipases A2 Homologues: Relevant Structural Features on Myotoxicity and Catalytic Inactivity
Protein & Peptide Letters Monoclonal Antibody Therapy in Haematological Malignancies
Current Clinical Pharmacology 5-HT2A Inverse-Agonists for the Treatment of Insomnia
Current Topics in Medicinal Chemistry Etiopathogenesis and Treatment of Parkinsons Disease
Current Topics in Medicinal Chemistry The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
CNS & Neurological Disorders - Drug Targets Predicting the Activity of ACE Inhibitory Peptides with a Novel Mode of Pseudo Amino Acid Composition
Protein & Peptide Letters